Thema: BRHYPEACNOR0
Hypera, BRHYPEACNOR0
stock-6687228_1920.jpg - Foto: THN
Hypera stock: Semavy becomes top-selling drug as Q3 profit rises
Hypera stock draws attention as Semavy becomes the drugmaker's top-selling product. Third-quarter profit rose as the new injection pen gained traction.
ad-hoc-news.de, heute 00:23 Uhr
Hypera, BRHYPEACNOR0
Hypera approves BRL 185 million interest payment: dividend ...
A BRL 0.26304 per-share payment was declared on September 23, 2026. Hypera stock also draws a BRL 480 million 2027 Semavy forecast.
ad-hoc-news.de, 16.10.26 01:40 Uhr
Hypera, BRHYPEACNOR0
Hypera declares BRL 0.26 dividend per share for Hypera stock ...
Second-quarter revenue reached BRL 2.34 billion, up 8.50 percent year on year. For Hypera stock this means BRL 490.24 million in net income.
ad-hoc-news.de, 06.10.26 00:30 Uhr
Hypera, BRHYPEACNOR0
Hypera stock gained 1.90 percent on October 2 before results ...
Hypera stock closed at BRL 25.16 on October 2, 2026, after a 1.90 percent daily gain. Q2 revenue rose 8.5 percent and net income increased 15 percent.
ad-hoc-news.de, 05.10.26 19:00 Uhr
Hypera, BRHYPEACNOR0
Hypera declares BRL 0.26 dividend: 15 analysts rate Hypera ...
Hypera grew second-quarter revenue 8.50 percent to BRL 2.34 billion year over year. 15 analysts rate Hypera stock Buy with a BRL 29.60 target.
ad-hoc-news.de, 02.10.26 00:52 Uhr
